title: Regulatory dendritic cells: new targets for cancer immunotherapy.
authors.affiliation: Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Shurin
authors.forename: Hiam
authors.initials: H
authors.lastname: Naiditch
authors.forename: Hua
authors.initials: H
authors.lastname: Zhong
authors.forename: Galina V
authors.initials: GV
authors.lastname: Shurin
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007167:Immunotherapy; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D019496:Cancer Vaccines; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase